Vanda Pharmaceuticals Inc. (VNDA) 8-K Current Report — March 10, 2026
Filed: March 10, 2026
Health Care
Pharmaceutical PreparationsVanda Pharmaceuticals Inc. (VNDA) 8-K current report filed with SEC EDGAR on March 10, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.
Reported 8-K Items1 item
- Item 7.01: Regulation FD Disclosure
Vanda Pharmaceuticals Inc. 8-K Mar 10, 2026 Event Analysis
Item 7.01 · Regulation FD Disclosure
- • Vanda Pharmaceuticals filed a Reg FD disclosure (Item 7.01), signaling a potentially market-moving communication to investors
- • No substantive disclosure content included in this section — material information likely contained in an accompanying exhibit
Other Vanda Pharmaceuticals Inc. 8-K Filings
Get deeper insights on Vanda Pharmaceuticals Inc.
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.